Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03627403
Title Selinexor in Myelofibrosis Refractory or Intolerant to JAK1/2 Inhibitors (ESSENTIAL)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Utah
Indications

myelofibrosis

Therapies

Selinexor

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Huntsman Cancer Institute/University of Utah Recruiting Salt Lake City Utah 84112 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field